Liabilities / Assets
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
53rd percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
57th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
16th percentile
Higher net margin than 16% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
48th percentile
Faster asset growth than 48% of similar nonprofits.
Revenue Growth
13th percentile
Faster revenue growth than 13% of similar nonprofits.
Assets
Up$43,757
Up $92 (+0.2%) from 2011
Net Assets
-
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2011
Revenue
Down$74,767
Down $43,926 (-37%) from 2011
Expenses
Up$90,002
Up $11,583 (+15%) from 2011
Net Income
Down-$15,235
Down $55,509 (-138%) from 2011
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To provide the leadership and resources needed to support increased research, accelerated diagnosis, improved health, and ultimately a cure for primary ciliary dyskinesia (pcd).
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2012 • Form 990EZSummary only. Only limited summary data is available for this year.